QZ and SU were trained within of the PhD program Metabolic and Cardiovascular Disease (DK-MCD) and Biomolecular Structures and Interactions (BioMolStruct)
Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process
At week 4, women in the treatment group displayed improved skin elasticity (+12.7%), reduced wrinkle volume (16.5%), decreased transepidermal water loss (10.8%), increased hydration (+3.5%), and enhanced collagen density compared with baseline values (measured via specialized skin analysis instrumentation)
In this article Key Takeaways GHK-Cu is a subcutaneous injection
BLU-945, a selective EGFR inhibitor, was tested in EGFR-mutated NSCLC (NCT04862780), while daraxonrasib, a RAS(ON) multiselective noncovalent tri-complex inhibitor, is being evaluated in both NSCLC (NCT06881784) and PDAC (NCT06625320)
Hundreds of rodent studies at high doses, no significant adverse effects documented